Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LO2A in moderate to severe conjunctivochalasis
NCT02810119Phase 2Completed
- Start
- Nov 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of artificial tears in conjunctivochalasis (CCH) (2 arms). Primary endpoint: Lissamine Green Conjunctival Staining at 3 months. Started Nov 2016; status: completed.
02
Drugs
artificial tears
03
Conditions
conjunctivochalasis (CCH)
Beyond the preview
Go deeper on NCT02810119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02810119.